Skip to main content
argenx SE (EBR:ARGX)
Belgium flag Belgium · Delayed Price · Currency is EUR
630.60
+8.40 (1.35%)
At close: Mar 9, 2026

argenx SE Revenue

In the year 2025, argenx SE had annual revenue of $4.25B USD with 88.95% growth. argenx SE had revenue of $1.32B in the quarter ending December 31, 2025, with 74.57% growth.

Revenue
$4.25B
Revenue Growth
+88.95%
P/S Ratio
10.67
Revenue / Employee
$2.66M
Employees
1,599
Market Cap
38.59B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.25B2.00B88.95%
Dec 31, 20242.25B979.61M77.22%
Dec 31, 20231.27B827.58M187.66%
Dec 31, 2022441.01M-87.25M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UCB SA 7.74B
Financière de Tubize 13.26K
Onward Medical 2.72M
Hyloris Pharmaceuticals 8.46M
European Medical Solutions 49.47M
Celyad Oncology 186.00K
BioSenic -2.39M
Oxurion NV 2.00K
Revenue Rankings

argenx SE News

More News